Letter: is it appropriate to use a fatty liver index >60 as an alternative criterion for non-alcoholic fatty liver disease?

Aliment Pharmacol Ther

Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Cancer Center, Affiliated People's Hospital of Hangzhou Medical College, Zhejiang Provincial People's Hospital, Hangzhou, China.

Published: July 2022

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.17041DOI Listing

Publication Analysis

Top Keywords

fatty liver
8
letter appropriate
4
appropriate fatty
4
liver >60
4
>60 alternative
4
alternative criterion
4
criterion non-alcoholic
4
non-alcoholic fatty
4
liver disease?
4
fatty
2

Similar Publications

-A Potential Source of Nutrients and Bioactive Components.

Plants (Basel)

December 2024

Department of Chemical Technology, Faculty of Chemistry, University of Plovdiv "Paisii Hilendarski", 24 Tzar Asen Street, 4000 Plovdiv, Bulgaria.

The Asteraceae family is a large plant family, with over 1600 genera and 25,000 species, most of which are generally herbaceous plants. This family's members are widely used in the human diet and medicine. One of the most popular representatives is L.

View Article and Find Full Text PDF

Background/objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) is diagnosed when hepatic steatosis is proven by imaging and one of the five cardiometabolic criteria is present. The relationship between MASLD and body composition components has recently received increased research attention. However, the five cardiometabolic criteria do not include components of body composition.

View Article and Find Full Text PDF

Earth's rotation around its axis has pressured its inhabitants to adapt to 24 h cycles of day and night. Humans adapted their own circadian rhythms to the Earth's rhythms with a light-aligned awake-sleep cycle. As a consequence, metabolism undergoes drastic changes throughout the circadian cycle and needs plasticity to cope with opposing conditions in the day (when there is an increase in energy demands and food availability), and during the night (when prolonged fasting couples with cyclic changes in the energy demands across the sleep stages).

View Article and Find Full Text PDF

Non-alcoholic fatty liver disease (NAFLD) is a major metabolic disorder with no established pharmacotherapy. Quercetin, a polyphenolic flavonoid, demonstrates potential hepatoprotective effects but has limited bioavailability. This study evaluates the impact of quercetin on NAFLD and assesses the roles of autophagy-related proteins in disease progression.

View Article and Find Full Text PDF

Background/objectives: Functional probiotics, particularly subsp. CKDB001, have shown potential as a therapeutic option for metabolic dysfunction-associated steatotic liver disease (MASLD). However, their effects have not been confirmed in in vivo systems.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!